Acrux Limited Stock Performance
| ARUXF Stock | USD 0.01 0.00 0.00% |
Acrux holds a performance score of 7 on a scale of zero to a hundred. The firm shows a Beta (market volatility) of -6.27, which signifies a somewhat significant risk relative to the market. As returns on the market increase, returns on owning Acrux are expected to decrease by larger amounts. On the other hand, during market turmoil, Acrux is expected to outperform it. Use Acrux maximum drawdown, as well as the relationship between the expected short fall and day typical price , to analyze future returns on Acrux.
Risk-Adjusted Performance
Fair
Weak | Strong |
Compared to the overall equity markets, risk-adjusted returns on investments in Acrux Limited are ranked lower than 7 (%) of all global equities and portfolios over the last 90 days. Despite nearly weak basic indicators, Acrux reported solid returns over the last few months and may actually be approaching a breakup point. ...more
| Begin Period Cash Flow | 15.3 M | |
| Total Cashflows From Investing Activities | -465 K |
Acrux |
Acrux Relative Risk vs. Return Landscape
If you would invest 5.00 in Acrux Limited on September 27, 2025 and sell it today you would lose (4.00) from holding Acrux Limited or give up 80.0% of portfolio value over 90 days. Acrux Limited is currently producing 4.0582% returns and takes up 42.6113% volatility of returns over 90 trading days. Put another way, most equities are less risky on the basis of their return distribution than Acrux, and majority of traded equity instruments are likely to generate higher returns over the next 90 trading days. Expected Return |
| Risk |
Acrux Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Acrux's investment risk. Standard deviation is the most common way to measure market volatility of pink sheets, such as Acrux Limited, and traders can use it to determine the average amount a Acrux's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.0952
| Best Portfolio | Best Equity | ARUXF | ||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Based on monthly moving average Acrux is performing at about 7% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Acrux by adding it to a well-diversified portfolio.
Acrux Fundamentals Growth
Acrux Pink Sheet prices reflect investors' perceptions of the future prospects and financial health of Acrux, and Acrux fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Acrux Pink Sheet performance.
| Return On Equity | -0.71 | |||
| Return On Asset | -0.43 | |||
| Operating Margin | (7.54) % | |||
| Current Valuation | 11.43 M | |||
| Shares Outstanding | 286.39 M | |||
| Price To Earning | (218.00) X | |||
| Price To Book | 2.72 X | |||
| Price To Sales | 9.75 X | |||
| Revenue | 1.72 M | |||
| EBITDA | (12.31 M) | |||
| Cash And Equivalents | 5.83 M | |||
| Cash Per Share | 0.02 X | |||
| Total Debt | 2.08 M | |||
| Debt To Equity | 0.23 % | |||
| Book Value Per Share | 0.03 X | |||
| Cash Flow From Operations | (8.82 M) | |||
| Earnings Per Share | (0.03) X | |||
| Total Asset | 14.3 M | |||
| Retained Earnings | (53 M) | |||
| Current Asset | 34 M | |||
| Current Liabilities | 6 M | |||
About Acrux Performance
By analyzing Acrux's fundamental ratios, stakeholders can gain valuable insights into Acrux's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if Acrux has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Acrux has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
Acrux Limited, together with its subsidiaries, develops and commercializes generic and topical pharmaceuticals in Australia, Europe, the United States, and internationally. The company was incorporated in 1998 and is based in West Melbourne, Australia. Acrux operates under Biotechnology classification in the United States and is traded on OTC Exchange.Things to note about Acrux Limited performance evaluation
Checking the ongoing alerts about Acrux for important developments is a great way to find new opportunities for your next move. Pink Sheet alerts and notifications screener for Acrux Limited help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Acrux Limited is way too risky over 90 days horizon | |
| Acrux Limited has some characteristics of a very speculative penny stock | |
| Acrux Limited appears to be risky and price may revert if volatility continues | |
| The company reported the revenue of 1.72 M. Net Loss for the year was (9.83 M) with loss before overhead, payroll, taxes, and interest of (4.65 M). | |
| Acrux Limited has accumulated about 5.83 M in cash with (8.82 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.02, which can makes it an attractive takeover target, given it will continue generating positive cash flow. | |
| Roughly 15.0% of the company shares are held by company insiders |
- Analyzing Acrux's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Acrux's stock is overvalued or undervalued compared to its peers.
- Examining Acrux's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Acrux's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Acrux's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Acrux's pink sheet. These opinions can provide insight into Acrux's potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for Acrux Pink Sheet analysis
When running Acrux's price analysis, check to measure Acrux's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Acrux is operating at the current time. Most of Acrux's value examination focuses on studying past and present price action to predict the probability of Acrux's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Acrux's price. Additionally, you may evaluate how the addition of Acrux to your portfolios can decrease your overall portfolio volatility.
| AI Portfolio Prophet Use AI to generate optimal portfolios and find profitable investment opportunities | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal |